We are live on ! Find out more
BC

Birchview Capital Portfolio holdings

AUM $176M
1-Year Est. Return 95.04%
This Fund
S&P 500
This Quarter Est. Return
+18.58%
1 Year Est. Return
+95.04%
3 Year Est. Return
+233.14%
5 Year Est. Return
+280.2%
10 Year Est. Return
+1,023.63%
AUM
$115M
AUM Growth
+$7.3M
Cap. Flow
-$5.59M
Cap. Flow %
-4.84%
Top 10 Hldgs %
66.83%
Holding
65
New
5
Increased
9
Reduced
7
Closed
4

Top Buys

Rank Stock Value
1
ACAD icon
Acadia Pharmaceuticals
ACAD
+$2.5M
2
EQT icon
EQT Corp
EQT
+$1.18M
3
ATEC icon
Alphatec Holdings
ATEC
+$844K
4
CSTL icon
Castle Biosciences
CSTL
+$611K
5
KALV
KalVista Pharmaceuticals
KALV
+$453K

Top Sells

Rank Stock Value
1
SILK
Silk Road Medical, Inc. Common Stock
SILK
+$4.27M
2
HROW icon
Harrow
HROW
+$2.61M
3
ETRN
Equitrans Midstream Corporation Common Stock
ETRN
+$1.73M
4
NBIX icon
Neurocrine Biosciences
NBIX
+$1.65M
5
OVV icon
Ovintiv
OVV
+$951K

Sector Composition

Rank Sector Weight
1 Healthcare 97.17%
2 Energy 2.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BLUE
51
DELISTED
bluebird bio
BLUE
$110K 0.1%
10,560
-5,000
-32% -$83.1K
ALMS
52
Alumis Inc
ALMS
$3.58B
$107K 0.09%
+10,000
New +$121K
LQDA icon
53
Liquidia Corp
LQDA
$6.94B
$100K 0.09%
10,000
– –
QURE icon
54
uniQure
QURE
$2.75B
$98.6K 0.09%
+20,000
New +$130K
IFRX icon
55
InflaRx
IFRX
$268M
$76.5K 0.07%
50,000
– –
TSVT
56
DELISTED
2seventy bio
TSVT
$74.7K 0.06%
15,833
-2,000
-11% -$9.02K
VTYX
57
DELISTED
Ventyx Biosciences
VTYX
$62.8K 0.05%
28,800
– –
ZNTL icon
58
Zentalis Pharmaceuticals
ZNTL
$359M
$58.9K 0.05%
16,000
– –
CABA icon
59
Cabaletta Bio
CABA
$452M
$47.2K 0.04%
10,000
– –
OM icon
60
Outset Medical
OM
$75.8M
$6.77K 0.01%
667
– –
CERO
61
DELISTED
CERo Therapeutics
CERO
$1.21K ﹤0.01%
6
– –
XOM icon
62
ExxonMobil
XOM
$615B
– –
-5,849
Closed -$673K
GTHX
63
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
– –
-80,000
Closed -$182K
SILK
64
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
– –
-158,094
Closed -$4.27M
ETRN
65
DELISTED
Equitrans Midstream Corporation Common Stock
ETRN
– –
-133,050
Closed -$1.73M
1 2
3

Similar funds

RWA
Resolute Wealth Advisor Findlay, Ohio $176M AUM
BAM
Boyar Asset Management New York $176M AUM 20.04% 1-Year Est. Return
TIM
Tevis Investment Management Plano, Texas $176M AUM 18.14% 1-Year Est. Return
TFCM
Taylor Frigon Capital Management Scottsdale, Arizona $176M AUM 24.25% 1-Year Est. Return
FPW
Flywheel Private Wealth Los Altos, California $176M AUM 26.12% 1-Year Est. Return
LWM
Lifetime Wealth Management Rockwall, Texas $176M AUM
PFA
Providence Financial Advisors Overland Park, Kansas $175M AUM
DAM
Draper Asset Management Smithtown, New York $176M AUM 37.45% 1-Year Est. Return

Birchview Capital's Q3 2024 Portfolio in Review

As of Q3 2024, Birchview Capital held 65 positions worth $115M, up 6.7% from $108M the previous quarter. Its ten largest holdings account for 67% of the portfolio.

Birchview Capital withdrew a net $5.59M in Q3 2024, closing 4 positions and reducing 7 holdings. Its most notable exit was Silk Road Medical, Inc. Common Stock, an estimated $4.27M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 97% of assets, up from 95% a quarter earlier, followed by Energy.

Against the trend, Birchview Capital opened a new position in EQT Corp worth $1.27M.

  • Birchview Capital's largest Q3 2024 buy was EQT Corp: 34,619 shares worth $1.27M.
  • Birchview Capital added most to Acadia Pharmaceuticals in Q3 2024, an estimated $2.5M increase.
  • Birchview Capital's biggest Q3 2024 reduction was Harrow, cutting an estimated $2.61M.
  • Birchview Capital fully exited Silk Road Medical, Inc. Common Stock in Q3 2024, selling an estimated $4.27M.
  • Birchview Capital's ten largest holdings make up 67% of its $115M portfolio in Q3 2024.
  • Birchview Capital opened 5 new positions and closed 4 in Q3 2024.
  • Birchview Capital's portfolio value rose 6.7% quarter-over-quarter to $115M.

Based on Birchview Capital's 13F filing for Q3 2024, filed 14 Nov 2024.